101 Written questions of Joanna KOPCIŃSKA
Regulation of the European Parliament and of the Council on health technology assessment and amending Directive 2011/24/EU
Emergency Response Coordination Centre (ERCC) and European Centre for Disease Prevention and Control (ECDC)
Poor access to medicines in the EU
Development of a unified EU brain health strategy
China: rapid spread of the Wuhan virus
Commission’s position on discrimination against Polish companies
Coronavirus cases in the EU
Action by the Commission in support of conservation measures in the Member States
The need to bring pharmaceutical production back to Europe
The European Network for Highly Infectious Diseases (EuroNHID)
The pharmaceutical strategy for Europe
EU4Health programme
Member States’ competences and the EU4Health programme
Immune passport and the COVID-19 epidemic
Methodology for assessing the treatment of COVID-19 patients
Increase in the spread of zoonotic diseases
The Commission’s research and innovation initiatives for addressing Campylobacteriosis and emerging zoonotic diseaes
The COVID-19 pandemic and the Farm to Fork Strategy
Food security
Impact assessment mechanism and objectives of the ‘Farm to Fork’ strategy
Reorientation of healthcare systems in the EU in the context of the Covid-19 pandemic
Remdesivir
EMA recommendations for distribution of the COVID-19 vaccine as soon as it is available
Maintaining the food supply chain against the backdrop of increasing COVID-19 infections
The Commission and consideration of tort law relating to liability of Member States for damages caused by a vaccine
ECDC and COVID-19 testing strategies
Recommendations for Member States concerning the duration quarantine
Updating the recommendations in view of rising Covid-19 cases
Distribution of COVID-19 vaccines
Herd immunity
COVID-19 vaccine
Pharmaceutical strategy for Europe
Support for low- and middle-income countries in accessing COVID-19 vaccines
Rapid growth of SARS-CoV-2 variant with multiple mutations observed in the UK
SARS-CoV-2 mutation and vaccines
Responsibility of vaccine manufacturers and potential pathways for viral mutation
Vaccine approval process
Link between biodiversity loss and the increasing spread of zoonotic diseases
Sequencing of SARS-CoV-2 and the new mutation of the virus
Commission support for Member States concerning accelerated testing for COVID-19
The role of EuroNHID and EU SHARP in expanding ECDC competences
Measure introducing an export licence requirement for Covid-19 vaccines
Assessment of EU Member States' health data laws in light of the GDPR and ECDC
Coronavirus mutations and revision of contracts with producers
Signing of an International Pandemic Treaty
The WHO’s call for further research and data on the origins of the SARS-CoV-2 virus
European Medicines Agency, AstraZeneca vaccine and clear information communication procedure
Long-term complications of COVID-19
Updating of EU industrial strategy
Antibody research
OECD and children's mental health
Delta variant
Rules on mask-wearing
Vaccinating children
Commission action concerning the use of a third dose of coronavirus vaccine
European Electronic Health Record exchange format
Vaccination and non-vaccination in virus transmission
Budget Amendment 6 – COVAX
Moderna and the Nordic states
Variant AY.4.2
Use of medicines to treat COVID-19 and the risk of antimicrobial resistance
REGEN-COV treatment
USA-EU and HERA
Omicron 2
Omicron 1
New contracts and hesitation over Omicron
Adverse event reporting (AER) to EudraVigilance during the Covid-19 pandemic
Criteria for antimicrobial labeling advice
War in Ukraine and the threat to the supply of medicines in Europe
Ukraine and public health in the Multiannual Indicative Programme 2021-27
Development of a health profile for Ukraine
Healthcare compensation fund and work synergies
European Health Data Space
Measles outbreak and COVID-19
Acute hepatitis
Variants BA.4 and BA.5
Change in the Commission’s position on Russia’s ultimatum on gas payments in roubles
Monkeypox
Transatlantic SCBTH agreement
European Monitoring Centre for Drugs and Drug Addiction
Provenance of strains of the updated COVID-19 vaccine
Increase in Covid-19 infections
Acute hepatitis of unknown aetiology
Titanium dioxide in food production
WHO statistics and long Covid
Financial Intermediary Fund
Report on the use of medicines for COVID-19
Recommendations on the use of antibiotic treatments in well-defined bacterial infections
Council recommendations on cancer and budget
Principles of the third EU4Health work programme
Role of the EMA’s MSSG and the HMA in the context of the medicines shortage
The European cancer imaging initiative and the GDPR
Recurrence of drug-resistant tuberculosis cases
Shortages of paediatric drugs in winter 2023-24
Epizootic haemorrhagic disease and EHDV
Respiratory diseases in autumn/winter
Sepsis
List and transposition mechanism of critical medicines categories
Methodological criteria for evaluating the Europe’s Beating Cancer Plan
Strategy for the development of biotechnology and biomanufacturing in the context of public health challenges in the EU
Avian influenza